Clinical Trial: Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07132827) titled 'Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps' on Aug. 13.

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of SHR-1905 injection in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP)

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Chronic Rhinosinusitis With Nasal Polyps

Intervention: DRUG: SHR-1905 Injection

SHR-1905 Injection

DRUG: SHR-1905 Placebo Injection

SHR-1905 Placebo Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

Disclaimer: Curated by HT Syn...